Alzheimer’s Disease and Frontal Temporal Dementia
Dear friends, families, carers, researchers and supporters… (Lewybody)
Summary: The Lewy Body Society marks its 20th anniversary, reflecting on its evolution from a small advocacy group into the UK’s only charity exclusively dedicated to Lewy body dementia. The organization highlights its partnerships with Newcastle University and the University of Liverpool, its public awareness work with patrons including Rob Rinder, and its vision for earlier diagnosis, sustained research investment, and improved care. The piece serves as both a retrospective and a forward-looking mission statement.

Why it matters: For readers tracking neurodegenerative disease policy and research funding, this anniversary signals the maturation of a focused advocacy infrastructure for LBD, a condition often overshadowed by Alzheimer’s and Parkinson’s. The charity’s emphasis on early diagnosis and research investment may influence UK dementia strategy priorities.
Context: Lewy body dementia is the second most common degenerative dementia after Alzheimer’s, yet it remains underdiagnosed and under-researched relative to its prevalence. The Lewy Body Society was founded in 2004 to address this gap.
"As we mark the 20th anniversary of the Lewy Body Society, we are filled with profound gratitude, pride and hope. What began in 2006 as a small but determined effort to shine." — LEWYBODY
Commentary: The explicit naming of Newcastle and Liverpool as research anchors signals where the UK’s LBD evidence base is concentrated. For funders and policymakers, this suggests that future breakthroughs will likely emerge from these hubs, and that sustained investment in their infrastructure is a high-leverage move. The absence of mention of any new clinical trials or diagnostic tools in the anniversary statement is notable—it implies the field remains in a foundational, rather than translational, phase.
Date: Tue, 02 Jun 2026 23:50:20 +0000
URL: https://www.lewybody.org/dear-friends-families-carers-researchers-and-supporters/
AI Sentiment Score: Negative (66%)
AI Credibility Score: 10.0/10 — High
Scores and text generated by AI analysis of the source article indicated.
Looking back over 20 years of Lewy Body Society history (Lewybody)
Summary: The Lewy Body Society, founded in 2006 by barrister Ashley Bayston after her mother’s diagnosis, has grown from a one-person effort into the first European charity focused exclusively on Lewy body dementia. Over two decades, it has raised an estimated £8 million, funded £3.4 million in research across 27 UK projects, answered 8,500 carer calls, and built a global network including World Lewy Body Day and the Lewy Body International coalition. The charity now marks its 20th anniversary with a £500,000 research call, a parliamentary event, and a new patron in Robert Rinder.

Why it matters: Lewy body dementia remains underdiagnosed and underfunded relative to its prevalence; the Society’s trajectory from a single founder to a globally networked organization with sustained policy access signals a maturing advocacy infrastructure that could shift research priorities and clinical awareness.
Context: Lewy body dementia affects an estimated 1.4 million people in the US alone but receives a fraction of the research funding of Alzheimer’s disease, and diagnostic criteria were only formally established in the 1990s by Professor Ian McKeith’s consortium.
"We remain, as we have always been, a small charity with a global reach – and an unshakeable belief that no one living with Lewy body dementia should be left behind." — LEWYBODY
Commentary: The Society’s 20-year arc—from a barrister’s kitchen table to hosting a global network and a dedicated awareness day—illustrates how disease-specific charities can bootstrap influence through persistent parliamentary engagement and community mobilization. The £500,000 research call and the shift to a second major fundraiser in two decades suggest a deliberate scaling strategy, but the real signal is the institutionalization of Lewy body dementia as a policy concern, not just a clinical one. The challenge ahead is whether this momentum can translate into the kind of NIH-level funding and pharmaceutical pipeline that Alzheimer’s has secured.
Date: Tue, 02 Jun 2026 22:35:34 +0000
URL: https://www.lewybody.org/looking-back-over-20-years-of-lewy-body-society-history/
AI Sentiment Score: Negative (87%)
AI Credibility Score: 10.0/10 — High
Scores and text generated by AI analysis of the source article indicated.
Profile – Annika Dhawan, King’s College London (Dementiaresearcher.Nihr.Ac.Uk)
Summary: Annika Dhawan, a research assistant at King’s College London, is working on the PALLDEM-Homecare project, funded by Marie Curie and Alzheimer’s Society, which focuses on dementia and palliative care. Her background includes an MSc in Clinical Mental Health Sciences from UCL and a BSc in Psychology with neuroscience from St Andrews. Dhawan’s research interests center on caregiver wellbeing and evidence-based psychological interventions for neurodegenerative conditions, emphasizing practical, real-world support in community and home-based settings.

Why it matters: This profile highlights the growing integration of palliative care into dementia research, a shift that directly addresses the unmet needs of families and caregivers—a critical gap in current dementia care pathways.
Context: The PALLDEM-Homecare project is a Marie Curie and Alzheimer’s Society-funded initiative at King’s College London, aiming to translate research into practical support for people living with dementia and their caregivers.
"I’m particularly interested in how research can translate into practical, day‑to‑day support that improves quality of life and wellbeing. Working in dementia allows me to contribute to work that is both clinically meaningful and grounded in real‑world experiences, especially in community and home‑based care settings." — DEMENTIARESEARCHER.NIHR.AC.UK
Commentary: Dhawan’s focus on translating research into daily support reflects a broader trend in dementia care toward pragmatic, community-based interventions rather than purely biomedical models. The emphasis on caregiver wellbeing acknowledges a critical but often under-resourced area, especially as most dementia care occurs at home. Her advice to early-career researchers—to seek feedback and build challenging relationships—underscores the collaborative, iterative nature of this applied field. This project may serve as a template for how palliative care principles can be adapted for neurodegenerative diseases, potentially influencing policy and practice in community dementia care.
Date: Tue, 02 Jun 2026 18:09:49 +0000
URL: https://www.dementiaresearcher.nihr.ac.uk/profile-annika-dhawan-kings-college-london/
AI Sentiment Score: Negative (62%)
AI Credibility Score: 10.0/10 — High
Scores and text generated by AI analysis of the source article indicated.
Exploring Ageing through National Datasets (Dementiaresearcher.Nihr.Ac.Uk)
Summary: A recent NCRM webinar showcased three quantitative approaches to studying ageing: a cross-generational life-course model for healthy ageing, pension protection disparities among UK minority ethnic groups, and the gap between subjective and chronological age across birth cohorts. The presentations, recorded for the Data Resources Training Network, are available on the NCRM YouTube channel.

Why it matters: For researchers and policymakers in dementia and ageing, these secondary data analyses offer methodological templates for identifying cohort-specific risk factors and systemic inequities that shape cognitive decline trajectories.
Context: The webinar reflects a growing emphasis on leveraging large-scale national datasets to move beyond clinical measures of ageing toward multidimensional, population-level insights.
"This National Centre for Research Methods (NCRM) webinar recording features presentations from three researchers on ways of exploring ageing using secondary quantitative data from national datasets. – George B. Ploubidis considers a." — DEMENTIARESEARCHER.NIHR.AC.UK
Commentary: The focus on subjective vs. chronological age is particularly relevant for dementia research, as perceived age may serve as an early marker of neuropathological change. The pension protection analysis also hints at how socioeconomic stressors in minority communities could compound dementia risk through reduced access to resources. These methodological approaches deserve closer attention from clinical trial designers seeking to stratify participants by more than just calendar age.
Date: Tue, 02 Jun 2026 17:15:09 +0000
URL: https://www.dementiaresearcher.nihr.ac.uk/exploring-ageing-through-national-datasets/
AI Sentiment Score: Negative (85%)
AI Credibility Score: 10.0/10 — High
Scores and text generated by AI analysis of the source article indicated.
Post ID: d4503a28
